A 3210-g girl was born at term to a 29-year-old mother following an uncomplicated pregnancy. The child had Apgars of 9 and 9 at 1 and 5 minutes, respectively. She was discharged on day of life 2, but began to feed poorly on day 4 and over the subsequent 24 hours became progressively more lethargic and was brought to the emergency room, where an echocardiogram demonstrated hypoplastic left heart with aortic atresia. Intravenous therapy of prostaglandin (0.05 g/kg/ minute), dopamine and dobutamine was begun. She was listed for cardiac transplant. Initial attempts at feeding were not successful and the child was begun on hyperalimentation. On day of life 25, the child was started on 2 ml/hr feedings, which were not tolerated. An abdominal sonogram and upper gastrointestinal series were obtained (Figures 1 and 2 ). These demonstrated a gastric outlet obstruction. The child was maintained on hyperalimentation because a nasojejunal tube could not be successfully passed through the pylorus. A heart transplant was performed on day of life 30. The first postoperative radiograph demonstrated extensive calcifications in the neck and axilla (Figure 3 ). The child, however, had progressively worsening cardiac function, Candida sepsis, and gastrointestinal bleeding and died on day of life 40.
DENOUEMENT AND DISCUSSION Hypoplastic Left Heart, Prostaglandin Therapy Gastric Focal Foveolar Hyperplasia and Brown-Fat Necrosis
The abdominal sonogram and upper gastrointestinal series demonstrate a gastric outlet obstruction and papillary mucosal thickening with alternating hyperechoic and hypoechoid bands. This is characteristic of focal foveolar hyperplasia (FHH) associated with prostaglandin therapy. The postoperative chest radiograph demonstrates lamellar calcifications in the distribution of brown fat. The appearance represents brown-fat necrosis and has been reported in patients on prostaglandin therapy. Prostaglandin E1 and E2 are widely used in neonates with congenital heart disease to ensure patency of the ductus arteriosus. It is widely used in patients with hypoplastic left heart syndrome, pulmonary atresia, hypoplastic pulmonary arteries, critical valvar pulmonic stenosis, coarctation of the aorta, and transposition of the great arteries.
1 Well-known complications of prostaglandin therapy include diarrhea, and hyperplastic osteopathy with thickened periosteum producing a neocortex. 1, 2 Gastric outlet obstruction due to FHH is a complication of prostaglandin therapy, which has increasingly been described in patients with high cumulative dose of prostaglandin E ( >1560 g/ kg). 3 The foveolae are pits of gastric mucosa that are normally longest in the antrum. FHH is a papillary hyperplasia of the antral mucosa, due to deepening of the foveolae and hyperplasia of the foveolar cells with increased mucin production. 4 ,5 FHH has been described in infants on prostaglandin and in adults with gastritis, bile reflux, or following Bilroth II procedure. 4 In adults not on prostaglandin, FHH is thought to be a response to gastric injury. 4 The exact role of prostaglandin therapy in producing FHH is thought to be an effect on foveolar cells causing delayed senescence and delayed exfoliation of foveolar cells. 5 Infants with prostaglandin therapy and FHH are usually symptomatic with gastric dilatation, abdominal distention, increased gastric aspirates, poor feeding, and vomiting. 1, 6 Symptoms usually improve after several weeks or months following the discontinuation of prostaglandin E.
The appearance on contrast upper gastrointestinal imaging is that of a polypoid mass with gastric outlet obstruction, which may mimic hypertrophic pyloric stenosis. 6 Sonography of FHH shows 1,3 a normal wall thickness, unlike pyloric stenosis. However, sonography also indicates that there is polypoid or papillary enlargement of the mucosa with alternating hyperechoic and hypoechoic bands. These bands probably represent alternating bands of mucosa and mucin laden crypts. 3 The association of brown-fat necrosis and prostaglandin therapy as occurred in this infant has only recently been described. 7 Brown fat is a very vascular deposit of fat in the neck, axilla, and interscapular areas associated with an extensive capillary plexus, so that every cell is in contact with a capillary wall. Brown fat is used in the production of body heat. In the presence of hypothermia, the brown fat is consumed. 7 Because of its extensive blood supply, brown fat is very sensitive to hypoperfusion. Necrosis of brown fat occurs at autopsy in 4% of infants who die with cyanotic congenital heart disease. Brownfat necrosis has an increased incidence in patients with severe congenital heart disease and prostaglandin therapy, because prostaglandin causes sclerosis of small arterioles. 7 Brown-fat necrosis 
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produces a characteristic pattern of calcification over the shoulders, neck and axilla (Raboi) as was seen in this patient. Herman and Siegel FFH Associated With Prostaglandin Therapy
